Vitrolife

Vitrolife OCF Margin

The Operating Cash Flow Margin of Vitrolife (VITR.ST) as of Nov 9, 2026 is 18.46 %. In the previous year, Operating Cash Flow Margin was 25.13 % — a change of -26.55% (lower).

OCF Margin

18.46 %

YoY

-26.55%

Last updated:

Operating Cash Flow Margin of Vitrolife is 2025 18.46 % . Operating Cash Flow Margin of Vitrolife was 2024 25.13 % . It decreases by -26.55% lower compared to the previous year.

The Vitrolife OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
30.35 SEK
Jan 1, 2019
27.93 SEK
Jan 1, 2020
28.62 SEK
Jan 1, 2021
22.86 SEK
Jan 1, 2022
19.67 SEK
Jan 1, 2023
21.55 SEK
Jan 1, 2024
25.13 SEK
Jan 1, 2025
18.46 SEK
The Vitrolife OCF Margin history
YEAROCF MarginYoY
18.46 %-26.55%
25.13 %+16.59%
21.55 %+9.60%
19.67 %-13.99%
22.86 %-20.10%
28.62 %+2.48%
27.93 %-7.99%
30.35 %+1.71%
29.84 %+40.93%
21.17 %-20.97%
26.79 %-6.11%
28.53 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vitrolife Stock analysis

What does Vitrolife do? Vitrolife AB is a Swedish biotech company specializing in the development and marketing of products for in vitro fertilization (IVF) and regenerative medicine. It was founded in 1994 and has over 390 employees worldwide. The company's main business is IVF, offering a wide range of essential products for IVF treatment such as culture media, devices for semen analysis and preparation, embryo transfer techniques, and products for biopsy examinations and cryopreservation. Vitrolife has a presence in 110 countries and has expanded its market to China where there is a high demand for fertility treatments. The company also offers medical equipment for regenerative treatments. Vitrolife is a leading player in the IVF industry known for its high product quality and innovation. It collaborates with universities and research institutions globally to improve IVF technology and success rates. The company places importance on sustainability and environmental protection, using 100% animal-free ingredients in their culture media and practicing recycling and waste reduction in their production facilities. In summary, Vitrolife offers a wide range of products for IVF and regenerative medicine, with a focus on supporting IVF treatments. The company is a leader in its industry and actively participates in research. It is committed to sustainability and environmental responsibility. Vitrolife is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vitrolife stock

Operating Cash Flow Margin of Vitrolife is 18.46 % in 2025.

Operating Cash Flow Margin of Vitrolife changed from 25.13 % to 18.46 %, representing a -26.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Vitrolife since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Vitrolife with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Vitrolife

All Key Metrics — Vitrolife